DENTSPLY SIRONA Inc. (XRAY)
- Sector
- Health Care
- Last price
- $8.44
- As of
Kresmion compiles this page from XRAY's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
DENTSPLY SIRONA Inc. (XRAY): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-09.
See the full XRAY dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for XRAY on one page. Preview it with sample data, then open it live with a free account.
Preview the XRAY dossierActive signals for XRAY
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 70% of XRAY (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +340% to XRAY (2026Q2)
- highINSTITUTIONAL_EXIT
RENAISSANCE TECHNOLOGIES LLC cut 98% of XRAY (2026Q2)
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 46.1%, EPS $0.52 vs $0.3558 estimate
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 81% of XRAY (2026Q1)
FREE, NO ACCOUNT
Every signal on XRAY, as it fires
You are seeing 5 of 10 signals recorded on XRAY since 2026-05-24.
The five above landed across 3 days. The other 5 were recorded on 2 other days. 5 of the 10 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in XRAY (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| D. E. Shaw & Co., Inc.CUSIP 24906P109 · 2026Q2 | $31.7M | 0.02% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 24906P109 · 2026Q2 | $9.1M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 24906P109 · 2026Q2 | $8.1M | 0.00% | , |
| Bridgewater Associates, LPCUSIP 24906P109 · 2026Q2 | $3.9M | 0.02% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 24906P109 · 2026Q2 | $1.3M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 24906P109 · 2026Q2 | $355K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, XRAY
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
XRAY against its peers
XRAY's operating margin of -11.5% ranks in the 14th percentile of 24 Health Care sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-01-03.
| Metric | XRAY | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 3.7B USD | 948M USD | 90 | 25 |
| Gross margin | 50.0% | 59.9% | 36 | 17 |
| Operating margin | -11.5% | 5.2% | 14 | 24 |
| Net margin | -16.3% | 1.1% | 21 | 25 |
| Return on equity | -44.7% | 3.8% | 14 | 24 |
| P / E | n/a | 38.3x | n/a | 13 |
| 1 year | -32.3% | 0.9% | 15 | 23 |
Peers (25): ATEC, NVCR, LMAT, OMCL, WGS, ALHC, INSP, SEM, PGNY, AMN, MD, PNTG, CERT, CNMD, OMDA, BKD, USPH, AVAH, PRVA, TMDX, TNDM, ACHC, GDRX, PRCT, IRMD. Fiscal periods ending between 2025-12-31 and 2026-01-03. Every figure is one full fiscal year read from one annual filing (XRAY: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow XRAY on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to XRAY for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.